Establishment of a patient-derived orthotopic osteosarcoma mouse model

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Blattmann, Claudia ^a,b   Thiemann, Markus ^a,b   Stenzinger, Albrecht ^a   Roth, Eva K ^a,b   Dittmar, Anne ^a   Witt, Hendrik ^a,b   Lehner, Burkhard ^a   Renker, Eva ^a   Jugold, Manfred ^b   Eichwald, Viktoria ^b   Weichert, Wilko ^a,b   Huber, Peter E ^a   Kulozik, Andreas E ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Mouse model; Osteosarcoma; Patient derived; Primary cell line; Xenograft

Indexed keywords

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALB/C NUDE MOUSE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOTOPIC TRANSPLANTATION; OSTEOSARCOMA; OSTEOSARCOMA CELL LINE; PALPATION; PHENOTYPE; TUMOR CELL INOCULATION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BONE TUMOR; CANCER TRANSPLANTATION; CELL CULTURE TECHNIQUE; DISEASE MODEL; MICRO-COMPUTED TOMOGRAPHY; NUDE MOUSE; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; TUMOR CELL LINE;

ADOLESCENT; ANIMALS; BONE NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA; PHENOTYPE; PROGNOSIS; RECURRENCE; X-RAY MICROTOMOGRAPHY;

EID: 84929166730     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0497-x     Document Type: Article

References (35)

1. Bielack SS, Kempf-Bielack B, Delling G, Exner BU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776-90.
2. Langdon SP. Animal modeling of cancer pathology and studying tumor response to therapy. Curr Drug Targets. 2012;13(12):1535-47.
3. Berns A. Mouse models of cancer. Mol Oncol. 2013;7:143-5.
4. Hiroshima Y, Zhang Y, Zhang N, Uehara F, Maawy A, Murakami T, et al. Patient-derived Orthotopic Xenograft (PDOX) nude mouse model of soft-tissue sarcoma more closely mimics the patient behavior in contrast to the subcutaneous ectopic model. Anticancer Res. 2015;35(2):697-701.
5. Brennecke P, Arlt MJ, Campanile C, Husmann K, Gvozdenovic A, Apuzzo T, et al. CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice. Clin Exp Metastasis. 2014;31(3):339-49.
6. Guijarro MV, Ghivizzani SC, Gibbs CP. Animal models in osteosarcoma. Front Oncol. 2014;4:182.
7. Crnalic S, Häkansson I, Boquist L, Löfvenberg R, Brostrom LA. A novel spontaneous metastasis model of human osteosarcoma developed using orthotopic transplantation of intact tumor tissue into tibia of nude mice. Clin Exp Metastasis. 1997;15(2):164-72.
8. Zhang Y, Ma Q, Liu T, Ke S, Jiang K, Wen Y, et al. Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms. J Cancer Res Clin Oncol. 2014;140(2):329-40.
9. Chan LH, Wang W, Yeung W, Deng Y, Yuan P, Mak KK. Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression. Oncogene. 2013;33(40):4857-66.
10. Brennecke P, Arlt MJ, Muff R, Campanile C, Gvozdenovic A, Husmann K, et al. Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice. PLoS One. 2013;8(9):e74045.
11. Fletcher CDM, Bridge J A, Hogendoorn P, Mertens F. WHO classification of tumours of soft tissue and bone. Volume 5. 4th ed. WHO Press.
12. Schmitt M, Pawlita M. High-throughput detection and multiplex identification of cell contaminations. Nucleic Acid Res. 2009;37:e119.
13. Solinas-Toldo S, Dürst M, Lichter P. Specific chromosomal imbalances in human papillomavirus-transfected cells during progression towardimmortality. Proc Natl Acad Sci U S A. 1997;94(8):3854-9.
14. Zielinski B, Gratias S, Toedt G, Mendrzyk F, Stange DE, Radlwimmer B, et al. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer. 2005;43(3):294-301.
15. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Döhner H, et al. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes, Chromosomes Cancer. 1997;20:399-407.
16. Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, et al. Outcome prediction in pediatric medulloblastoma based on dna copy-number aberrations of chromosomes 6q and 17q and the myc and mycn loci. J Clin Oncol. 2009;27(10):1627-36.
17. Carrle D, Bielack SS. Current strategies of chemotherapy in osteosarcoma. Int Orthop. 2006;30(6):445-51.
18. Salzer-Kuntschik M, Brand G, Delling G. Bestimmung des morphologischen regressionsgrades nach chemotherapie bei malignen knochentumoren. Pathologie. 1983;4:135-41.
19. Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, et al. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer. 2004;4:45.
20. Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev. 2014;40(4):523-32.
21. Ta HT, Dass CR, Choong PF, Dunstan DE. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009;28(1-2):247-63.
22. Blattmann C, Thiemann M, Stenzinger A, Christmann A, Roth E, Ehemann V, et al. Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model. Strahlenther Onkol. 2013;189(11):957-66.
23. Pignochino Y, Dell'Aglio C, Basiricò M, Capozzi F, Soster M, Marchiò S, et al. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models. Clin Cancer Res. 2013;19(8):2117-31.
24. Chaffee BK, Allen MJ. A clinically relevant mouse model of canine osteosarcoma with spontaneous metastasis. In Vivo. 2013;27(5):599-603.
25. Rao-Bindal K, Rao CK, Yu L, Kleinerman ES. Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts. Pediatr Blood Cancer. 2013;60(4):575-9.
26. Cole HA, Ohba T, Ichikawa J, Nyman JS, Cates JM, Haro H, et al. Micro-Computed Tomography Derived Anisotropy Detects Tumor Provoked Deviations in Bone in an Orthotopic Osteosarcoma Murine Model. PLoS One. 2014;9(6):e97381.
27. Vormoor B, Knizia HK, Batey MA, Almeida G, Wilson I, Dildey P, et al. Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging. PLoS One. 2014;9(1), e85128.
28. Folkvord S, Ree AH, Furre T, Halvorsen T, Flatmark K. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status. Int J Radiat Oncol Biol Phys. 2009;74:546-52.
29. Sicklick JK, Leonard SY, Babicky ML, Tang C-M, Mose ES, French RP, et al. Generation of orthotopic patient-derived xenografts from gatsrointestinal stromal tumor. J Transl Med. 2014;12:41.
30. Wong NC, Bhadri VA, Maksimovic J, Parkinson-Bates M, Ng J, Craig JM, et al. Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance. BMC Genomics. 2014;15:416.
31. Zhang H, Cohen AL, Krishnakumar S, Wapnir IL, Veeriah S, Deng G, et al. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition. Breast Cancer Res. 2014;16(2):R36.
32. Wagner AJ. Patient-derived sarcoma xenografts for individual-patient selection of chemotherapy-ready for prime time? Cancer. 2014;120(13):1917-9.
33. Stebbing J, Paz K, Schwartz GK, Wexler LH, Maki R, Pollock RE, et al. Patient-derived xenografts for individualized care in advanced sarcoma. Cancer. 2014;120(13):2006-15.
34. Blattmann C, Oertel S, Thiemann M, Weber KJ, Schmezer P, Zelezny O, et al. Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation. Strahlenther Onkol. 2012;188(2):168-76.
35. Oertel S, Thiemann M, Richter K, Weber KJ, Huber PE, Perez RL, et al. Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines. Radiat Oncol. 2011;6:119.